Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Indian J Exp Biol ; 2004 Aug; 42(8): 758-65
Artigo em Inglês | IMSEAR | ID: sea-59247

RESUMO

L-Lysine HCI is being proposed to be a possible biocompatible adjuvant to enhance immune response by virtue of its probable non-specific bridging action and cellular proliferation properties. This proposal has been tried to be substantiated by designing an in vitro culture protocol, varying the concentration of L-lysine HCI and its further in vivo application. Splenic lymphocyte population has been extracted from mice and co-cultured with extracted mice macrophage population in presence of either Bacille Calmette Guerrin (BCG) or Hepatitis B surface antigen (HbsAg) and added L-lysine hydrochloride in culture media. Post incubation of these cultures, "taught" cell population has been adoptively transferred in naïve mice. These mice were then challenged by respective antigen dose, Change in Immune response with this challenge was noted. Antibody titre was followed in all the experiments as a measure of immune response. In adoptive immune transfer experiment of with HbsAg (AIT-HbsAg), similar to that with BCG (AIT-BCG), after the incubation period, antibody titre was higher in added lysine containing cultures in comparison with the control ones. Post transfer followed by antigen challenge, in AIT-BCG the expected augmentation in immune response was hardly visible. But in AIT-HbsAg, with the help of lysine booster, the animals responded better as far as the antibody titre is concerned.


Assuntos
Animais , Vacina BCG/administração & dosagem , Feminino , Vacinas contra Hepatite B/administração & dosagem , Fatores Imunológicos/administração & dosagem , Imunoterapia Adotiva , Lisina/administração & dosagem , Camundongos , Camundongos Endogâmicos BALB C , Vacinas contra a Tuberculose/administração & dosagem
2.
Indian J Physiol Pharmacol ; 2001 Jul; 45(3): 367-72
Artigo em Inglês | IMSEAR | ID: sea-108791

RESUMO

Monoclonal antibodies (MAb) constitute the centre of all in-vitro diagnostic measures and almost all in-vivo therapeutic manoeuvres now. Production emphasis for these antibodies is having a current shift from animal-based large-scale culture to in-vitro bioreactor-based high-density culture. One of the major difficulties in high-density culture is end-metabolite accumulation in batch and fed-batch cultures in the forms of H+, NH4+ etc.. thereby reducing cellular growth and secretions. In the present study, effects of added proton carries--NAD and NADP--over and above the metabolic pools of the molecules, were examined on the cellular growth and secretion kinetics. Although NADP fortification showed a remarkable improvement in cellular growth (time dependent 200-300% improvements compared to controls) and size, cumulative MAb titre was better with NAD fortification. Combined additional loads of the proton carriers would be interesting to study in high density culture conditions.


Assuntos
Algoritmos , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Meios de Cultura , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Hibridomas/efeitos dos fármacos , Lisina/farmacologia , Camundongos , Muromonab-CD3/biossíntese , NAD/farmacologia , Prótons , Espectrofotometria Ultravioleta , Estimulação Química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA